These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 20851597
1. Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). Greimel E, Nordin A, Lanceley A, Creutzberg CL, van de Poll-Franse LV, Radisic VB, Galalae R, Schmalz C, Barlow E, Jensen PT, Waldenström AC, Bergmark K, Chie WC, Kuljanic K, Costantini A, Singer S, Koensgen D, Menon U, Daghofer F, EORTC Quality of Life Group. Eur J Cancer; 2011 Jan; 47(2):183-90. PubMed ID: 20851597 [Abstract] [Full Text] [Related]
2. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24. Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic V, Wydra D, European Organization for Research and Treatment of Cancer Quality-of-Life Group. Cancer; 2006 Oct 15; 107(8):1812-22. PubMed ID: 16977652 [Abstract] [Full Text] [Related]
3. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, Van Cutsem E, D'haese S, Coens C, European Organisation for Research and Treatment of Cancer Gastrointestinal and Quality of Life Groups. Eur J Cancer; 2004 Oct 15; 40(15):2260-8. PubMed ID: 15454251 [Abstract] [Full Text] [Related]
4. Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24). Stukan M, Zalewski K, Mardas M, Filarska D, Szajewski M, Kmieć A, Bińkowska P, Pietrzak-Stukan M, Dudziak M, Grabowski JP, Eskander RN, Greimel E. Eur J Cancer Care (Engl); 2018 Jan 15; 27(1):. PubMed ID: 28058740 [Abstract] [Full Text] [Related]
5. An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. Arraras JI, Greimel E, Sezer O, Chie WC, Bergenmar M, Costantini A, Young T, Vlasic KK, Velikova G. Eur J Cancer; 2010 Oct 15; 46(15):2726-38. PubMed ID: 20674333 [Abstract] [Full Text] [Related]
6. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Lagergren P, Fayers P, Conroy T, Stein HJ, Sezer O, Hardwick R, Hammerlid E, Bottomley A, Van Cutsem E, Blazeby JM, European Organisation for Research Treatment of Cancer Gastrointestinal and Quality of Life Groups. Eur J Cancer; 2007 Sep 15; 43(14):2066-73. PubMed ID: 17702567 [Abstract] [Full Text] [Related]
7. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A, EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups. Eur J Cancer; 2010 Apr 15; 46(6):1033-40. PubMed ID: 20181476 [Abstract] [Full Text] [Related]
8. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. Park KU. Oncology; 2008 Apr 15; 74 Suppl 1():7-12. PubMed ID: 18758191 [Abstract] [Full Text] [Related]
9. Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours. Davies AH, Larsson G, Ardill J, Friend E, Jones L, Falconi M, Bettini R, Koller M, Sezer O, Fleissner C, Taal B, Blazeby JM, Ramage JK, EORTC Quality of Life Group. Eur J Cancer; 2006 Mar 15; 42(4):477-84. PubMed ID: 16412628 [Abstract] [Full Text] [Related]
10. Patients' acceptance and psychometric properties of the EORTC QLQ-CX24 after surgery. Singer S, Kuhnt S, Momenghalibaf A, Stuhr C, Dimmel-Hennersdorf U, Köhler U, Einenkel J. Gynecol Oncol; 2010 Jan 15; 116(1):82-7. PubMed ID: 19836828 [Abstract] [Full Text] [Related]
11. The EORTC QLQ-HDC29: a supplementary module assessing the quality of life during and after high-dose chemotherapy and stem cell transplantation. Velikova G, Weis J, Hjermstad MJ, Kopp M, Morris P, Watson M, Sezer O, EORTC Quality of Life Group. Eur J Cancer; 2007 Jan 15; 43(1):87-94. PubMed ID: 17081744 [Abstract] [Full Text] [Related]
12. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module. Shin DW, Ahn E, Kim YM, Kang S, Kim BG, Seong SJ, Cha SD, Park CY, Yun YH. Oncology; 2009 Jan 15; 76(3):190-8. PubMed ID: 19209009 [Abstract] [Full Text] [Related]
13. Validation of the EORTC QLQ-SAT32 cancer inpatient satisfaction questionnaire by self- versus interview-assessment comparison. Brédart A, Mignot V, Rousseau A, Dolbeault S, Beauloye N, Adam V, Elie C, Léonard I, Asselain B, Conroy T. Patient Educ Couns; 2004 Aug 15; 54(2):207-12. PubMed ID: 15288916 [Abstract] [Full Text] [Related]
14. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients. Jayasekara H, Rajapaksa LC, Greimel ER. Psychooncology; 2008 Oct 15; 17(10):1053-7. PubMed ID: 18203241 [Abstract] [Full Text] [Related]
15. French version of FACT-G: validation and comparison with other cancer-specific instruments. Conroy T, Mercier M, Bonneterre J, Luporsi E, Lefebvre JL, Lapeyre M, Puyraveau M, Schraub S. Eur J Cancer; 2004 Oct 15; 40(15):2243-52. PubMed ID: 15454249 [Abstract] [Full Text] [Related]
16. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J, EORTC Quality of Life Group. Eur J Cancer; 2007 Jul 15; 43(11):1670-8. PubMed ID: 17574838 [Abstract] [Full Text] [Related]
17. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30. Guzelant A, Goksel T, Ozkok S, Tasbakan S, Aysan T, Bottomley A. Eur J Cancer Care (Engl); 2004 May 15; 13(2):135-44. PubMed ID: 15115469 [Abstract] [Full Text] [Related]
18. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. Blazeby JM, Currie E, Zee BC, Chie WC, Poon RT, Garden OJ, EORTC Quality of Life Group. Eur J Cancer; 2004 Nov 15; 40(16):2439-44. PubMed ID: 15519517 [Abstract] [Full Text] [Related]
19. Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. Pezzilli R, Morselli-Labate AM, Fantini L, Campana D, Corinaldesi R. Dig Liver Dis; 2007 Dec 15; 39(12):1077-86. PubMed ID: 17692582 [Abstract] [Full Text] [Related]
20. Patient preference for either the EORTC QLQ-C30 or the FACIT Quality Of Life (QOL) measures: a study performed in patients suffering from carcinoma of an unknown primary site (CUP). Rodary C, Pezet-Langevin V, Garcia-Acosta S, Lesimple T, Lortholary A, Kaminsky MC, Bennouna J, Culine S, Bourgeois H, Fizazi K. Eur J Cancer; 2004 Mar 15; 40(4):521-8. PubMed ID: 14962718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]